Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
Barrett, Jeffrey C
Hinsley, Wes R
Ariani, Cristina V
Loman, Nicholas J
McCrone, John T
Jackson, David K
COVID-19 Genomics UK (COG-UK) consortium,
MetadataShow full item record
Volz, E., Mishra, S., Chand, M., Barrett, J. C., Johnson, R., Geidelberg, L., Hinsley, W. R., et al. (2021). Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.. Nature, 593 (7858), 266-269. https://doi.org/10.1038/s41586-021-03470-x
The SARS-CoV-2 lineage B.1.1.7, designated variant of concern (VOC) 202012/01 by Public Health England1, was first identified in the UK in late summer to early autumn 20202. Whole-genome SARS-CoV-2 sequence data collected from community-based diagnostic testing for COVID-19 show an extremely rapid expansion of the B.1.1.7 lineage during autumn 2020, suggesting that it has a selective advantage. Here we show that changes in VOC frequency inferred from genetic data correspond closely to changes inferred by S gene target failures (SGTF) in community-based diagnostic PCR testing. Analysis of trends in SGTF and non-SGTF case numbers in local areas across England shows that B.1.1.7 has higher transmissibility than non-VOC lineages, even if it has a different latent period or generation time. The SGTF data indicate a transient shift in the age composition of reported cases, with cases of B.1.1.7 including a larger share of under 20-year-olds than non-VOC cases. We estimated time-varying reproduction numbers for B.1.1.7 and co-circulating lineages using SGTF and genomic data. The best-supported models did not indicate a substantial difference in VOC transmissibility among different age groups, but all analyses agreed that B.1.1.7 has a substantial transmission advantage over other lineages, with a 50% to 100% higher reproduction number.
COVID-19 Genomics UK (COG-UK) consortium, Humans, Age Distribution, Evolution, Molecular, Phylogeny, Genome, Viral, Time Factors, Adolescent, Adult, Aged, Aged, 80 and over, Middle Aged, Child, Child, Preschool, Infant, Infant, Newborn, England, Basic Reproduction Number, Young Adult, Spike Glycoprotein, Coronavirus, COVID-19, SARS-CoV-2
COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the UK National Institute for Health Research (NIHR), and Genome Research (operating as the Wellcome Sanger Institute).
Embargo Lift Date
External DOI: https://doi.org/10.1038/s41586-021-03470-x
This record's URL: https://www.repository.cam.ac.uk/handle/1810/325208
All rights reserved